Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With <i>Clostridioides difficile</i>
In patients aged ≥70 years with CDI, an intervention combining hospital-at-home care and FMT is cost-effective compared with standard treatment. The cost-effectiveness is mainly driven by fewer hospital admission days.
Authors
- Tone Rubak (ORCID: https://orcid.org/0000-0003-4496-391X)
- Christian Lodberg Hvas (ORCID: https://orcid.org/0000-0001-7973-7184)
- Rasmus H. Olesen
- Simon Mark Dahl Baunwall (ORCID: https://orcid.org/0000-0002-5135-7435)
- Lars Holger Ehlers (ORCID: https://orcid.org/0000-0001-6512-5566)
- Merete Gregersen (ORCID: https://orcid.org/0000-0002-5365-7335)
- Christian Erikstrup (ORCID: https://orcid.org/0000-0001-6551-6647)
- Sara Ellegaard Paaske (ORCID: https://orcid.org/0009-0006-7469-9995)
- C Krogh
- Emma Bendix Larsen (ORCID: https://orcid.org/0000-0002-9317-4194)
- Catherine Hauerslev Foss
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Institute of Health Economics (CA)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1093/cid/ciaf104
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Novo Nordisk Fonden